Mats Ehinger

Long-term progression-free survival of mantle cell lymphoma after intensive front-line immunochemotherapy with in vivo–purged stem cell rescue: a nonrandomized phase 2 multicenter study by the Nordic Lymphoma Group

Christian H. Geisler, Arne Kolstad, Anna Laurell et al. · Blood · 2008 · 624 citations · Full text

Medicine, Hematology, Oncology +13

CD146 expression on primary nonhematopoietic bone marrow stem cells is correlated with in situ localization

Ariane Tormin, Li Ou, Jan C. Brune et al. · Blood · 2011 · 462 citations · Full text

Life Sciences, Cell Biology, Hematology +11

Induction of apoptosis in U937 human leukemia cells by suberoylanilide hydroxamic acid (SAHA) proceeds through pathways that are regulated by Bcl-2/Bcl-XL, c-Jun, and p21CIP1, but independent of p53

J A Vrana, Roy H. Decker, C R Johnson et al. · Oncogene · 1999 · 286 citations

Life Sciences, Cancer Biology, Oncology +14

Nordic <scp>MCL</scp>2 trial update: six‐year follow‐up after intensive immunochemotherapy for untreated mantle cell lymphoma followed by <scp>BEAM</scp> or <scp>BEAC</scp> + autologous stem‐cell support: still very long survival but late relapses do occur

Christian H. Geisler, Arne Kolstad, Anna Laurell et al. · British Journal of Haematology · 2012 · 272 citations

Medicine, Immunology, Oncology +13

Induced disruption of the transforming growth factor beta type II receptor gene in mice causes a lethal inflammatory disorder that is transplantable

Per Levéen, Jonas Larsson, Mats Ehinger et al. · Blood · 2002 · 259 citations · Full text

Life Sciences, Genetics, Immunology +16